Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.
Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS.
Prabhu JS, et al. Among authors: kaul r.
Transl Oncol. 2017 Aug;10(4):699-706. doi: 10.1016/j.tranon.2017.04.011. Epub 2017 Jul 11.
Transl Oncol. 2017.
PMID: 28704710
Free PMC article.